EVARF — Lombard Medical Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Brief: Lombard Medical names david milne to board of directors
Brief: Lombard Medical acquires endovascular stent graft developer Altura Medical
Brief: Lombard Medical reports Q2 loss per share $0.51
Brief: First clinical cases performed using Lombard medical's Aorfix(TM) plus endovascular stent graft
Brief: Lombard Medical says signed 3-year group purchasing deal with Novation
Brief: Lombard Medical Q1 loss per share $0.59
Brief: Lombard Medical Q4 loss per share $0.51
Brief: Lombard Medical receives FDA approval for Aorfix(TM)plus endovascular stent graft
Brief: Lombard Medical appoints William Kullback as CFO